HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two
TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second precision diagnostic partnership program (“PDP Two”) with QIAGEN Manchester Limited
- Category:
- Press Releases